Goodrich Petroleum (GDP) Suspends Q4 Dividends on Series B, C Preferred Stock

Goodrich Petroleum (NYSE: GDP) announced that it has suspended the quarterly dividends for the quarter ending December 31, 2015 on its 5.375% Series B Cumulative Convertible Preferred Stock ("Series B"), its 10.00% Series C Cumulative Preferred Stock ("Series C"), and its 9.75% Series D Cumulative Preferred Stock ("Series D").

Under the terms of the Series B, Series C and Series D, any unpaid dividends, including the unpaid dividends for the quarter ending December 31, 2015 and any future unpaid dividends, will accumulate. If the Company does not pay dividends on its Series B, Series C and Series D for six quarterly periods (whether consecutive or non-consecutive), the holders of each series of preferred stock will have the right to elect two additional directors to serve on the Company's Board of Directors until all accumulated and unpaid dividends are paid in full. The dividend rate per annum on the Series B will be increased 1% per annum until all accumulated and unpaid dividends are paid in full.

The Series B was issued in 2005 and 2006 and trades on the OTCQB market under the symbol "GDPAN". The Series C was issued on April 10, 2013 and trades on the New York Stock Exchange ("NYSE") under the symbol "GDP-C". The Series D was issued on August 19, 2013 and trades on the NYSE under the symbol "GDP-D".

As previously announced, the Company has filed a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission which offers to exchange all issued and outstanding shares of Series B, up to 2,390,000 depository shares of Series C, and up to 2,390,000 depository shares of Series D for newly issued depositary shares representing a 1/1000th ownership interest in a share of the Company's 10.00% Series E Cumulative Convertible Preferred Stock. The tender offer will expire at 5:00 p.m., New York City time, on December 8, 2015, unless extended or earlier terminated by the Company.

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• Tarsus Pharmaceuticals (TARS) Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
• Peoples Bancorp (PEBO) Declares $0.40 Quarterly Dividend; 5.6% Yield